13 Recruiting Type 2 Diabetes Phase 2 Clinical Trials
Active phase 2 studies for type 2 diabetes enrolling across the USA. Verify eligibility and contact site coordinators.
All Type 2 Diabetes studiesPhase 2 Studies for Type 2 Diabetes
Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Who Are Not Achieving Glycemic Targets
📍 Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
View Study & Checklist ➔A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and Obesity
📍 Medical Advancement Centers of Arizona — Phoenix, Arizona
View Study & Checklist ➔The Medically Reproducing Bariatric Surgery (MRB) II Study
📍 Greenville VA Health Care Center — Greenville, North Carolina
View Study & Checklist ➔Renal Mechanism of SGLT2 Inhibition
📍 University of Colorado Denver — Aurora, Colorado
View Study & Checklist ➔Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers
📍 Medicine Invention Design, Inc. - IORG0007849 - NPI-1023387701 — Rockville, Maryland
View Study & Checklist ➔Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
📍 Institut de recherches cliniques de Montréal (IRCM) — Montreal, Quebec
View Study & Checklist ➔A1Cantus vs. Placebo
📍 UCR Health — Riverside, California
View Study & Checklist ➔Polypill for Prevention of Cardiomyopathy
📍 UT Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
📍 Central Research Associates, LLC dba Flourish Research — Birmingham, Alabama
View Study & Checklist ➔Exercise and Intranasal Insulin in Type 2 Diabetes
📍 Robert Wood Johnson University Hospital Clinical Research Center — New Brunswick, New Jersey
View Study & Checklist ➔Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
📍 Arizona Clinical Trials - Pecos — Chandler, Arizona
View Study & Checklist ➔A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
📍 Helios Clinical Research - Phoenix — Phoenix, Arizona
View Study & Checklist ➔HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
📍 Alliance Clinical Canoga Park (Hope Clinical Research) — Canoga Park, California
View Study & Checklist ➔